These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10551380)

  • 21. Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: methods and clinical relevance.
    Lin L; Libbrecht L; Verbeeck J; Verslype C; Roskams T; van Pelt J; Van Ranst M; Fevery J
    J Med Virol; 2009 Sep; 81(9):1569-75. PubMed ID: 19626615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR.
    Hayashi J; Yoshimura E; Kishihara Y; Yamaji K; Etoh Y; Ikematsu H; Kashiwagi S
    Am J Gastroenterol; 1996 Feb; 91(2):314-8. PubMed ID: 8607499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
    Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
    Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.
    Féray C; Gigou M; Samuel D; Paradis V; Mishiro S; Maertens G; Reynés M; Okamoto H; Bismuth H; Bréchot C
    Gastroenterology; 1995 Apr; 108(4):1088-96. PubMed ID: 7698576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection.
    Fernández I; Castellano G; Domingo MJ; Fuertes A; Colina F; Canga F; de la Cruz FJ; de la Cámara AG; Solís JA
    Scand J Gastroenterol; 1997 Jan; 32(1):70-6. PubMed ID: 9018770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.
    Zampino R; Marrone A; Durante Mangoni E; Santarpia L; Sica A; Tripodi MF; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2004 May; 73(1):33-7. PubMed ID: 15042645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of HCV RNA in liver of patients with chronic hepatitis C.
    Martinelli A; Brown D; Morris A; Dhillon A; Dayley P; Dusheiko G
    Arq Gastroenterol; 2000; 37(4):203-7. PubMed ID: 11469223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
    Manns M; Samuel D; Gane EJ; Mutimer D; McCaughan G; Buti M; Prieto M; Calleja JL; Peck-Radosavljevic M; Müllhaupt B; Agarwal K; Angus P; Yoshida EM; Colombo M; Rizzetto M; Dvory-Sobol H; Denning J; Arterburn S; Pang PS; Brainard D; McHutchison JG; Dufour JF; Van Vlierberghe H; van Hoek B; Forns X;
    Lancet Infect Dis; 2016 Jun; 16(6):685-697. PubMed ID: 26907736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus in body fluids after liver transplantation.
    Caldwell SH; Sue M; Bowden JH; Dickson RC; Driscoll CJ; Yeaton P; Stevenson WC; Ishitani MB; McCullough CS; Pruett TL; Lovell MA
    Liver Transpl Surg; 1996 Mar; 2(2):124-9. PubMed ID: 9346637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
    Charlton M
    Liver Transpl; 2003 Nov; 9(11):S58-62. PubMed ID: 14586897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
    Reedy DW; Loo AT; Levine RA
    Dig Dis Sci; 1998 Sep; 43(9):2156-9. PubMed ID: 9753286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC; Kodali VP; Silverman AL; Dmuchowski CF; Urdea MS; Chan CS; Wilber JC
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum hepatitis C virus titers in the progression of type C chronic liver disease. With special emphasis on patients with type 1b infection.
    Kao JH; Lai MY; Chen PJ; Hwang LH; Chen DS
    J Clin Gastroenterol; 1996 Dec; 23(4):280-3. PubMed ID: 8957730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
    J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implications.
    Dickson RC; Mizokami M; Orito E; Qian KP; Lau JY
    Transplantation; 1999 Nov; 68(10):1512-6. PubMed ID: 10589948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease.
    Anand BS; Velez M
    World J Gastroenterol; 2004 Aug; 10(16):2409-11. PubMed ID: 15285030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.